Anavex Life Sciences Corp.
AVXL
NGS
Sector: Healthcare
Industry: Biotechnology
8.32
USD
-0.19
(-2.23%)
Optionable: Yes Market Cap: 710 M 90-day average vol: 1,182,668
Previous close: 8.51 Open: 8.5 Bid: 8.6 Ask: 8.6
52 week range
7.13 15.24
Last updated: Wednesday 29th March 2023
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Financials
AVXL Cash Flow
Annual
Save
| Sep-13 | Sep-14 | Sep-15 | Sep-16 | Sep-17 | Sep-18 | Sep-19 | Sep-20 | Sep-21 | Sep-22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cashflowfinancing_Auditor's Report (aud. name & aud. op.) | UE | UQ | UQ | UQ | UQ | UQ | UQ | UQ | UQ | UQ | |
| Cashflowfinancing_Auditor's name (aud. name & aud. op.) | "BDO USA | LLP" | "BDO USA | LLP" | "BDO USA | LLP" | "BDO USA | LLP" | "BDO USA | LLP" | Grant Thornton LLP |
| Cashflowfinancing_Cash at beginning of period | 11362 | 345074 | 7 M | 15 M | 9 M | 27 M | 23 M | 22 M | 29 M | 152 M | |
| Cashflowfinancing_Cash at end of period | 345074 | 7 M | 15 M | 9 M | 27 M | 23 M | 22 M | 29 M | 152 M | 149 M | |
| Cashflowfinancing_Cash from disc. financing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Domestic sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Effect of exchange rate changes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Foreign sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Issuance of capital stock | 801285 | 368170 | 12 M | 3 M | 27 M | 8 M | 18 M | 29 M | 159 M | 22 M | |
| Cashflowfinancing_Issuance of debt | 250000 | 10 M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Net cash from financing activities | 1 M | 10 M | 12 M | 3 M | 27 M | 8 M | 18 M | 28 M | 153 M | 21 M | |
| Cashflowfinancing_Net change in cash & cash equivalents | 333712 | 7 M | 8 M | -6 M | 18 M | -5 M | -745008 | 7 M | 123 M | -3 M | |
| Cashflowfinancing_Other financing charges net | 60000 | -788712 | 0 | 0 | 0 | -101133 | -50000 | -403764 | -6 M | -706877 | |
| Cashflowfinancing_Payment of cash dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Repayment of debt | 0 | 0 | -88144 | -34759 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowfinancing_Repurchase of capital stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Cash from disc. investing activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Net cash from investing activities | 0 | -3015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Other investing changes net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Purchase of Float term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Purchase of property plant & equipment | 0 | -3015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Purchase of short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Sale of Float term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Sale of property plant equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowinvesting_Sale of short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_(Increase) Decrease in inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_(Increase) Decrease in other current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_(Increase) Decrease in other current liabilities | 0 | 0 | 0 | 0 | 0 | 262059 | 587009 | 2 M | 2 M | 330179 | |
| Cashflowoperating_(Increase) Decrease in other working capital | 465911 | -303018 | 1 M | 774250 | 484177 | 0 | 0 | 0 | 443831 | 0 | |
| Cashflowoperating_(Increase) Decrease in payables | 0 | 0 | 0 | 0 | 0 | 38233 | 683797 | 465722 | 750727 | -915004 | |
| Cashflowoperating_(Increase) Decrease in prepaid expenses | 0 | -33234 | -67692 | -131675 | -155804 | -915870 | 803196 | 57159 | 88290 | 1387 | |
| Cashflowoperating_(Increase) Decrease in receivables | 0 | 0 | -76840 | -2507 | 54435 | -231096 | -772388 | -2 M | -4 M | 6 M | |
| Cashflowoperating_Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Amortization of intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Deferred income taxes | N/A | -1 M | 0 | 0 | N/A | N/A | N/A | N/A | N/A | N/A | |
| Cashflowoperating_Depreciation | 576 | 768 | 995 | 1252 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Extraordinary (gains) losses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Net cash from continuing operations | -777573 | -3 M | -4 M | -9 M | -9 M | -13 M | -19 M | -21 M | -30 M | -24 M | |
| Cashflowoperating_Net cash from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Net cash from operating activities | -777573 | -3 M | -4 M | -9 M | -9 M | -13 M | -19 M | -21 M | -30 M | -24 M | |
| Cashflowoperating_Net income (loss) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Operating (gains) losses | 490391 | 9 M | -103525 | -58140 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cashflowoperating_Other non-cash items | 978095 | 3 M | 5 M | -145572 | -75204 | 0 | 35375 | 0 | 0 | 0 |
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today
Get started today